Need professional-grade analysis? Visit stockanalysis.com
$2.99B
N/A
258
N/A
Dyne Therapeutics Inc (DYN) trades on United States in USD. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at $19.21, down 5.88% from the previous close.
Over the past year, DYN has traded between a low of $8.18 and a high of $24.29. The stock has gained 78.2% over this period. It is currently 20.9% below its 52-week high.
Dyne Therapeutics Inc has a market capitalization of $2.99B.
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Side-by-side comparison against top Healthcare peers.